Eledon Pharmaceuticals Inc (ELDN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $178.63M
Last updated: Nov 17, 2026 at 11:05 AM ET
Eledon Pharmaceuticals Inc (ELDN) Earnings: Report Dates and Results
Eledon Pharmaceuticals (ELDN) is expected to report earnings on Mar 17, 2027. In the quarter ended Sep 30, 2026, Eledon Pharmaceuticals reported EPS of -$0.18, above the -$0.20 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ELDN has an expected report date of Mar 17, 2027.
Earnings History
Of the 39 quarters below that had an estimate, ELDN beat 22, missed 16 and matched 1. The widest gap in the table came in the quarter ended Jun 30, 2024, when EPS landed 231.25% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.18 | -$0.20 | -$0.21 - -$0.15 | +10.00% | Beat | N/A | 4 | 1 up, 2 down | Nov 12, 2026 |
| Jun 30, 2026 | -$0.19 | -$0.19 | -$0.19 - -$0.09 | 0.00% | In line | N/A | 4 | 2 up, 0 down | Aug 13, 2026 |
| Mar 31, 2026 | -$0.33 | -$0.26 | N/A | -26.92% | Miss | N/A | 2 | 0 up, 1 down | May 13, 2026 |
| Dec 31, 2025 | -$0.10 | -$0.20 | -$0.26 - -$0.17 | +50.00% | Beat | N/A | 6 | 3 up, 0 down | Mar 19, 2026 |
| Sep 30, 2025 | -$0.21 | -$0.25 | -$0.32 - -$0.16 | +16.00% | Beat | N/A | 6 | 2 up, 2 down | Nov 14, 2025 |
| Jun 30, 2025 | -$0.13 | -$0.23 | -$0.31 - -$0.13 | +43.48% | Beat | N/A | 6 | 3 up, 0 down | Aug 14, 2025 |
| Mar 31, 2025 | -$0.08 | -$0.30 | -$0.32 - -$0.28 | +73.33% | Beat | N/A | 3 | 0 up, 1 down | May 14, 2025 |
| Dec 31, 2024 | -$0.95 | -$0.33 | -$0.37 - -$0.29 | -189.44% | Miss | N/A | 6 | 0 up, 0 down | Mar 20, 2025 |
| Sep 30, 2024 | -$0.32 | -$0.31 | -$0.37 - -$0.20 | -3.23% | Miss | N/A | 4 | 0 up, 0 down | Nov 12, 2024 |
| Jun 30, 2024 | -$1.06 | -$0.32 | -$0.36 - -$0.23 | -231.25% | Miss | N/A | 5 | 0 up, 0 down | Aug 19, 2024 |
| Mar 31, 2024 | -$0.34 | -$0.33 | -$0.41 - -$0.33 | -3.03% | Miss | N/A | 4 | 0 up, 0 down | May 9, 2024 |
| Dec 31, 2023 | -$0.29 | -$0.39 | -$0.45 - -$0.35 | +25.64% | Beat | N/A | 5 | 0 up, 0 down | Mar 28, 2024 |
| Sep 30, 2023 | -$0.35 | -$0.41 | -$0.72 - -$0.38 | +14.63% | Beat | N/A | 5 | 0 up, 0 down | Nov 9, 2023 |
| Jun 30, 2023 | -$0.40 | -$0.45 | -$0.52 - -$0.39 | +11.11% | Beat | N/A | 5 | 0 up, 0 down | Aug 10, 2023 |
| Mar 31, 2023 | -$0.75 | -$0.74 | -$0.74 - -$0.46 | -1.35% | Miss | N/A | 2 | 0 up, 0 down | May 11, 2023 |
| Dec 31, 2022 | -$0.69 | -$0.70 | -$0.78 - -$0.50 | +1.43% | Beat | N/A | 4 | 0 up, 0 down | Mar 30, 2023 |
| Sep 30, 2022 | -$0.73 | -$0.69 | -$0.71 - -$0.64 | -5.80% | Miss | N/A | 5 | 0 up, 0 down | Nov 14, 2022 |
| Jun 30, 2022 | -$0.65 | -$0.72 | -$0.75 - -$0.62 | +9.72% | Beat | N/A | 5 | 0 up, 0 down | Aug 11, 2022 |
| Mar 31, 2022 | -$0.69 | -$0.68 | -$0.86 - -$0.52 | -1.47% | Miss | N/A | 4 | 0 up, 0 down | May 12, 2022 |
| Dec 31, 2021 | -$0.60 | -$0.79 | -$0.92 - -$0.57 | +24.05% | Beat | N/A | 5 | N/A | Mar 24, 2022 |
| Sep 30, 2021 | -$0.66 | -$0.65 | -$0.71 - -$0.58 | -1.54% | Miss | N/A | 5 | N/A | Nov 11, 2021 |
| Jun 30, 2021 | -$0.50 | -$3.76 | N/A | +86.70% | Beat | N/A | 4 | N/A | Aug 12, 2021 |
| Mar 31, 2021 | -$0.57 | -$0.32 | -$0.41 - -$0.19 | -78.13% | Miss | N/A | 4 | N/A | May 13, 2021 |
| Dec 31, 2020 | -$0.69 | -$1.76 | -$3.60 - -$0.16 | +60.80% | Beat | N/A | 3 | N/A | Mar 30, 2021 |
| Sep 30, 2020 | -$5.51 | -$1.75 | N/A | -214.86% | Miss | N/A | N/A | N/A | Nov 16, 2020 |
| Jun 30, 2020 | -$2.70 | -$2.97 | N/A | +9.09% | Beat | N/A | N/A | N/A | Aug 14, 2020 |
| Mar 31, 2020 | -$3.49 | -$2.88 | N/A | -21.18% | Miss | N/A | N/A | N/A | May 15, 2020 |
| Dec 31, 2019 | -$3.24 | -$4.68 | N/A | +30.77% | Beat | N/A | N/A | N/A | Mar 17, 2020 |
| Sep 30, 2019 | -$3.96 | -$7.29 | N/A | +45.68% | Beat | N/A | N/A | N/A | Nov 13, 2019 |
| Jun 30, 2019 | -$6.30 | -$7.65 | N/A | +17.65% | Beat | N/A | N/A | N/A | Aug 13, 2019 |
| Mar 31, 2019 | -$9.36 | -$8.73 | N/A | -7.22% | Miss | N/A | N/A | N/A | May 14, 2019 |
| Dec 31, 2018 | -$8.82 | -$7.20 | N/A | -22.50% | Miss | N/A | N/A | N/A | Mar 28, 2019 |
| Sep 30, 2018 | -$6.66 | -$7.20 | N/A | +7.50% | Beat | N/A | N/A | N/A | Nov 13, 2018 |
| Jun 30, 2018 | -$6.12 | -$5.58 | N/A | -9.68% | Miss | N/A | N/A | N/A | Aug 7, 2018 |
| Mar 31, 2018 | -$6.48 | -$5.22 | N/A | -24.14% | Miss | N/A | N/A | N/A | Apr 2, 2018 |
| Sep 30, 2017 | -$7.74 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 8, 2017 |
| Jun 30, 2017 | -$23.76 | -$48.60 | N/A | +51.11% | Beat | N/A | N/A | N/A | Aug 9, 2017 |
| Mar 31, 2017 | -$27.54 | -$48.60 | N/A | +43.33% | Beat | N/A | N/A | N/A | May 3, 2017 |
| Dec 31, 2016 | -$27.54 | -$55.08 | N/A | +50.00% | Beat | N/A | N/A | N/A | Mar 3, 2017 |
| Sep 30, 2016 | -$66.42 | -$68.85 | N/A | +3.53% | Beat | N/A | N/A | N/A | Nov 3, 2016 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.52, after -$2.67 the year before. It was -$325.62 for the year ended Dec 31, 2015, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.52 | N/A |
| Dec 31, 2024 | -$2.67 | N/A |
| Dec 31, 2023 | -$1.79 | N/A |
| Dec 31, 2022 | -$2.76 | N/A |
| Dec 31, 2021 | -$2.33 | N/A |
| Dec 31, 2020 | -$12.39 | N/A |
| Dec 31, 2019 | -$22.86 | N/A |
| Dec 31, 2018 | -$87.12 | N/A |
| Dec 31, 2016 | -$273.78 | N/A |
| Dec 31, 2015 | -$325.62 | N/A |
Frequently Asked Questions About ELDN
When is Eledon Pharmaceuticals's next earnings date?
Eledon Pharmaceuticals's next earnings report is expected for Mar 17, 2027.
Did ELDN beat earnings estimates last quarter?
Yes. Eledon Pharmaceuticals reported EPS of -$0.18 for the quarter ended Sep 30, 2026, above the -$0.20 estimate, a 10.00% surprise.
What EPS do analysts expect from ELDN next quarter?
The consensus EPS estimate for Eledon Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.17 from 7 analysts, with estimates from -$0.22 to -$0.01.
How often does ELDN beat earnings estimates?
Eledon Pharmaceuticals beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of -2.94%.
ELDN pages: Overview, Earnings, Forecast, Financials, Competitors